Journal of the Korean Association of Oral and Maxillofacial Surgeons

  • 제32권3호
  • /
  • Pages.200-208
  • /
  • 2006
  • /
  • 2234-7550(pISSN)
  • /
  • 2234-5930(eISSN)
대한구강악안면외과학회 (The Korean Association of Oral and Maxillofacial Surgeons)
권호 표지

사람 골육종 세포 Saos2에서 아미노산 수송계 L의 발현 및 기능적 특성

EXPRESSION AND FUNCTIONAL CHARACTERIZATION OF AMINO ACID TRANSPORT SYSTEM L IN SAOS2 HUMAN OSTEOGENIC SARCOMA CELLS

  • 김수관 (조선대학교 치과대학 구강악안면외과학교실) ;
  • 김현호 (조선대학교 치과대학 구강악안면외과학교실) ;
  • 김창현 (조선대학교 치과대학 구강생리학교실) ;
  • 김도경 (조선대학교 치과대학 구강생리학교실)
  • Kim, Su-Gwan (Dept. of Oral & Maxillofacial Surgery, College of Dentistry, Chosun University) ;
  • Kim, Hyun-Ho (Dept. of Oral & Maxillofacial Surgery, College of Dentistry, Chosun University) ;
  • Kim, Chang-Hyun (Dept. of Oral Physiology, College of Dentistry, Chosun University) ;
  • Kim, Do-Kyung (Dept. of Oral Physiology, College of Dentistry, Chosun University)
  • 발행 : 2006.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Amino acids are required for protein synthesis and energy sources in all living cells. The amino acid transport system L is a major nutrient transport system that is responsible for $Na^+$-independent transport of neutral amino acids including several essential amino acids. In malignant tumors, the L-type amino acid transporter 1 (LAT1), the first isoform of system L, is highly expressed to support tumor cell growth. In the present study, the expression and functional characterization of amino acid transport system L were, therefore, investigated in Saos2 human osteogenic sarcoma cells. RT-PCR and western blot analyses have revealed that the Saos2 cells expressed the LAT1 and the L-type amino acid transporter 2 (LAT2), the second isoform of system L, together with their associating protein heavy chain of 4F2 antigen (4F2hc) in the plasma membrane, but the expression of LAT2 was very weak. The uptakes of [${14}^C$]L-leucine by Saos2 cells were $Na^+$-independent and were completely inhibited by the system L selective inhibitor, 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH). The affinity of [${14}^C$]L-leucine uptake and the inhibition profiles of [${14}^C$]L-leucine uptake by various amino acids in the Saos2 cells were comparable with those for the LAT1 expressed in Xenopus oocytes. The majority of [${14}^C$]L-leucine uptake is, therefore, mediated by LAT1 in the Saos2 cells. These results suggest that the transports of neutral amino acids including several essential amino acids into Saos2 human osteogenic sarcoma cells are for the most part mediated by LAT1. Therefore, the Saos2 human osteogenic sarcoma cells are excellent tools for examine the properties of LAT1. Moreover, the specific inhibition of LAT1 in tumor cells might be a new rationale for anti-tumor therapy.

키워드

참고문헌

  1. Christensen HN: Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 1990;70:43-77 https://doi.org/10.1152/physrev.1990.70.1.43
  2. Silbernagl S: Renal transport of amino acids. Klin Wochenschr 1979;57:1009-1019 https://doi.org/10.1007/BF01479986
  3. Gomes P, Soares-da-Silva P: L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4. Brain Res 1999;829:143-150 https://doi.org/10.1016/S0006-8993(99)01387-6
  4. Goldenberg GJ, Lam HY, Begleiter A: Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. J Biol Chem 1979;254:1057-1064
  5. Blondeau JP, Beslin A, Chantoux F, Francon J: Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem 1993;60:1407-1413 https://doi.org/10.1111/j.1471-4159.1993.tb03302.x
  6. Su TZ, Lunney E, Campbell G, Oxender DL: Transport of gabapentin, a gamma-amino acid drug, by system 1 alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem 1995;64:2125-2131 https://doi.org/10.1046/j.1471-4159.1995.64052125.x
  7. Lakshmanan M, Goncalves E, Lessly G, Foti D, Robbins J: The transport of thyroxine into mouse neuroblastoma cells, NB41A3: the effect of L-system amino acids. Endocrinology 1990;126:3245-3250 https://doi.org/10.1210/endo-126-6-3245
  8. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H: Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Bio Chem 1998;273:23629-23632 https://doi.org/10.1074/jbc.273.37.23629
  9. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al: Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001;1514:291-302 https://doi.org/10.1016/S0005-2736(01)00384-4
  10. Uchino H, Kanai Y, Kim DK, Wempe MF, Chairoungdua A, Morimoto E, et al: Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanism of substrate recognition. Mol Pharmacol 2002;61:729-7378 https://doi.org/10.1124/mol.61.4.729
  11. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, et al: Amino-acid tramsport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 1998;395:288-291 https://doi.org/10.1038/26246
  12. Pfeiffer R, Spindler B, Loffing J, Skelly PJ, Shpemaker CB, Verrey F: Functional heterodimeric amino acid transporters lacking cysteine residues involved in disulfide bond. FEBS Lett 1998;439:157-162 https://doi.org/10.1016/S0014-5793(98)01359-3
  13. Mannion BA, Kolesnikova TV, Lin SH, Wang S, Thompson NL, Hemler ME: The light chain of CD98 is identified as E16/TA1 protein. J Biol Chem 1998;273:33127-33129 https://doi.org/10.1074/jbc.273.50.33127
  14. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, et al: 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 1999;274:3009-3016 https://doi.org/10.1074/jbc.274.5.3009
  15. Sang J, Lim YP, Panzica M, Finch P, Thompson NL: TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res 1995;55:1152- 1159
  16. Wolf DA, Wang S, Panzica MA, Bassily NH, Thompson NL: Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 1996;56:5012-5022
  17. Verrey F, Meier C, Rossier G, Kuhn LC: Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity. Pflugers Arch 2000;440:503-512 https://doi.org/10.1007/s004240000274
  18. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, et al: Identification of a membrane protein, LAT-2, that co-expressed with 4F2 heavy chain, an L-type amino acid transporter activity with broad specificity for small large zwitterionic amino aicds. J Biol Chem 1999;274:19738-19744 https://doi.org/10.1074/jbc.274.28.19738
  19. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, Kanai Y: Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999;274:19745-19751 https://doi.org/10.1074/jbc.274.28.19745
  20. Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, et al: LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kindney and intestine. J Biol Chem 1999;274:34948-34954 https://doi.org/10.1074/jbc.274.49.34948
  21. Utsunomiya-Tate N, Endou H, Kanai Y: Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter. J Biol Chem 1996;271:14883-14890 https://doi.org/10.1074/jbc.271.25.14883
  22. Utsunomiya-Tate N, Endou H, Kanai Y: Tissue specific variants of glutamate transporter GLT-1. FEBS Lett 1997;416:312-316 https://doi.org/10.1016/S0014-5793(97)01232-5
  23. Kim DK, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, et al: Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 2002;1565:112-121 https://doi.org/10.1016/S0005-2736(02)00516-3
  24. Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarily to H+/monocarboxylate transporters. J Biol Chem 2001;276:17221-17228 https://doi.org/10.1074/jbc.M009462200
  25. Kim DK, Kanai Y, Masuo H, Kim JY, Chairoungdua A, Kobayashi Y, et al: The human T-type amino acid transporter-1, characterization, gene oranization and chromosomal location. Genomics 2002;79:95-103 https://doi.org/10.1006/geno.2001.6678
  26. Kim DK, Yoon JH, Jeon JE, Lee SH: Expression and functional characterization of neutral amino acid transporter in Hep2 human head and neck squamous cell Carcinoma. Int J Oral Biol 2004;29:51-58
  27. Tai KW, Chou MY, Hu CC, Yang JJ, Chang YC: Induction of apoptosis in KB cells by pingyangmycin. Oral Oncol 2000;36:242-247 https://doi.org/10.1016/S1368-8375(99)00086-X
  28. Kok SH, Hong CY, Kuo MY, Lee CH, Lee JJ, Lou Iu, et al: Comparison of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes. Oral Oncol 2003;39:19-26 https://doi.org/10.1016/S1368-8375(01)00129-4